approached significanceP = 0.051
The association between the XRCC1 Gln allelic variants and reduced OS in stage II/III patients approached significance (HR = 1.41, 95% CI = 1.00–1.99, P = 0.051, FDR = 0.510).
The association between the XRCC1 Gln allelic variants and reduced OS in stage II/III patients approached significance (HR = 1.41, 95% CI = 1.00–1.99, P = 0.051, FDR = 0.510).